Prevention of Corticosteroid-induced Glucose Intolerance
Phase 3
- Conditions
- Glucose Intolerance
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2011-09-14
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 100
- Registration Number
- NCT00240604
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Phase 3
Withdrawn
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndrome
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 203
- Registration Number
- NCT00226512
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
Genetic Determinants of Opioids Analgesia
Not Applicable
Completed
- Conditions
- Nephrolithiasis
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 100
- Registration Number
- NCT00226564
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
Prediction of Drug Interactions With CYP2C9 Substrates
Not Applicable
Completed
- Conditions
- Healthy Volunteers
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 16
- Registration Number
- NCT00226538
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
Vascular Response to Isoproterenol and ฮฒ2 Adrenergic Receptor Polymorphisms
Not Applicable
Completed
- Conditions
- Coronary Disease
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2008-10-29
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 100
- Registration Number
- NCT00226551
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
Effect of Metal Skin Sensitivity on Restenosis After Stent Implantation
Not Applicable
- Conditions
- Coronary Stent Restenosis
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2006-11-07
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 150
- Registration Number
- NCT00226525
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Center, Jerusalem, Israel
Study of Different Concentrations of Epidural Bupivacaine for the Effects on Vasodilatation and Sensory Block
Phase 3
Completed
- Conditions
- Intraoperative Complications
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 60
- Registration Number
- NCT00197353
- Locations
- ๐ฎ๐ฑ
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction
Phase 3
Completed
- Conditions
- Pre-EclampsiaFetal Growth Retardation
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT00197340
- Locations
- ๐ฎ๐ฑ
Hadassah Hebrew University Medical Center, POB 12000, Jerusalem, Israel
Effectiveness of Circular Muscle Exercise (Paula Method) Versus Kegel Exercise for Urinary Stress Incontinence
Phase 3
Completed
- Conditions
- Urinary Stress Incontinence (SI)
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-11-07
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 200
- Registration Number
- NCT00197314
- Locations
- ๐ฎ๐ฑ
Dr. Ora Paltiel, Jerusalem, Israel
Liposomal Based Intranasal Influenza Vaccine:Safety and Efficacy
Phase 1
Completed
- Conditions
- Influenza
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-11-07
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 200
- Registration Number
- NCT00197301
- Locations
- ๐ฎ๐ฑ
Hadassah Medical Organization, Jerusalem, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath